AJ

Abhigya Jain

Active Director Director DIN 10081623
DIN 10081623 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Abhigya Jain

Data last updated:

Abhigya Jain is a Director at Vaccicare Life Sciences Private Limited (since 2023). The company operates in Pharma. Vaccicare Life Sciences Private Limited reported revenue of ₹8.2 Lakh (FY 2024).

DIN 10081623
Primary Designation Director
Industry Pharma
First Appointment 31 May 2023
Oldest Company Age 19 yrs
Largest company Vaccicare Life Sciences Private Limited · ₹8.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 May 20232007₹8.2 Lakh (FY 2024)Active

Board colleagues of Abhigya Jain

NameDINCompanyDesignation
Virendra Jain01857391Vaccicare Life Sciences Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Vaccicare Life Sciences Private Limited
Premium access

Shareholding and investment profile for Abhigya Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhigya Jain

Abhigya Jain currently holds 1 directorship: Vaccicare Life Sciences Private Limited (Director, since 31 May 2023, revenue ₹8.2 Lakh (FY 2024)).

Abhigya Jain was first appointed on 31 May 2023 as Director at Vaccicare Life Sciences Private Limited.

The current boards of Abhigya Jain's companies include Virendra Jain (Vaccicare Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available